Ominpod tubeless pump

Association of British Clinical Diabetologists

Omnipod Worldwide Audit

Home Live ABCD audits of new therapies and devices All ABCD nationwide audits Future audits of new therapies ABCD worldwide audits
Above In a randomised controlled trial, the Omnipod System improved glycaemic control measured by time in the glucose range of 39100 mmol/L by an average daily proportion of 6% more than multiple daily insulin injections (MDI) without any occurrences of severe hypoglycaemia. However, biochemical hypoglycaemia also was increased. It will be of interest to see what happens to these measurements when patients are initiated on Omnipod in the real world. The audit should provide this information
If HbA1c high bigger impact

Above In a study comparing adults switched from MDI to Omnipod system to a matched cohort who maintained MDI, the Omnipod group had a lower HbA1c and total daily insulin dose with significant improvements in those with HbA1c≥75mmol/mol (≥9%). Will these findings be reproduced when patients undergo the same switch in our real world audit. The audit should provide this information
Improvement following transition to tubeless
Above A multicenter, retrospective study suggested that initiating tubeless insulin pump therapy following transition from either MDI or CSII with a tubed insulin pump was a associated with significant improvement in HbA1C most notably in those with A1C ≥9.0% and those previously treated with MDI. In this context it will be of interest to see if these results will be replicated in the UK and elsewhere in the world is the same being found? The audit should provide this information
German registry data
Above - German registry data suggested that that tubeless insulin pump therapy is associated with good glycaemic control and a low frequency of DKA and severe hypoglycaemia in an age group prone to acute complications. What about in the UK and elsewhere in the world is the same being found? The audit should tell us
Improved QOL
Above - A study in California of quality of life (QOL) amongst Omnipod users found substantial QOL benefits among users. What about QOL in real world users in the UK and elsewhere in the world will the same be found? The audit should tell us

ABCD worldwide Omnipod audit

ABCD worldwide Omnipod audit
Following the success of the first audit of a device, the FreeStyle Libre audit, this audit is the fourth device related audit and it is due to launch before the end 2021. Insights into the sorts of helpful information learned from previous ABCD audits that has helped improve patient care in the past, can be gained through this link:, though this is by no means comprehensive: Centres worldwide are invited to join the Omnipod audit.

About the ABCD worldwide Omnipod audit

Omnipod is a tubeless insulin pump system. On the left you will find examples of findings from published research suggesting improvements in glycaemic control, acute diabetes complications and quality of life associated with this technology rather than multiple daily insulin injections or CSII with a tubed insulin pump. As with previous ABCD audits both of therapies and devices, the aim of this audit is to establish the extent to which such published findings will also be found when the Omnipod system is used in real clinical practice in the UK and elsewhere. The audit has a number of objectives.

Web-based audit tool
The audit tool for the Omnipod audit is similar to that being used for the other ABCD audits. The tool is easy to use. All data is encrypted and secured to a high level and is fully GDPR compliant meaning it has optimum security for patient identifiable data with regard to your own patients but anonymises the data when it is utilised in the national and global audit. There are some special features with regard to the data export both for your own local analysis and for the nationwide analysis. The export now allows you to choose which data to download for analysis as well as providing all data. It also allows you to choose to download the data aggregated to different time points.

Structure of the audit centres and sites
For this audit the concept of centres and sites is utilised in the same way as in the other ABCD audits. Typically, a centre might be an NHS Trust. Sites might be hospitals associated with that Trust, and/or health centres or GP surgeries in the local vicinity. If set up in this structure, designated leaders of the local audit would be given access to download the anonymised data of all the patients associated with the centre for more powerful local analysis of data involving higher numbers. Findings so made through such local analysis could be put forward for further testing on the full national dataset. Outside the UK, instead of centres and sites, contributors are registered as country and centre within that country.

Collect data on-line or via paper forms
The on-line audit tool will be so easy to use that live data entry in clinic is a real option to be considered. Otherwise, to facilitate data collection during clinics there are two paper forms which exactly match the data that can be entered into the audit tool.

To download the forms to printout for use, use the following links:

Download first visit data entry form
Download follow up visit data entry form

Caldicott Guardian approval
The ABCD audit programme has Caldicott Guardian approval. The programme is audit not research. The NHS encourages audit of clinical practice and there are strict guidelines which we follow, in particular that we only to collect data from routine clinical practice, and analysis is of data which is anonymised.

Further information
Further enquiries may be made to the ABCD nationwide audits database administrator of the project, Melissa Cull.


    Register for the Omnipod Audit

Access the on-line tool

Omnipod audit objectives

Download first visit data entry form

Download follow up visit data entry form

Download first visit data entry form (editable)

Download follow up visit data entry form (editable)

 Brief Guide for international centres

Papers, abstracts, presentations, posters from the audit

Further information- contact us

ABCD on HSCN homepage

Main ABCD homepage


The ABCD worldwide Omnipod audit is an independent audit supported by an unrestricted grant from Insulet

Working to support high quality diabetes care in the UK